Seeking Alpha

Novartis (NVS) CEO Joe Jimenez says the company may make bolt-on purchases of $2-4B but doesn't...

Novartis (NVS) CEO Joe Jimenez says the company may make bolt-on purchases of $2-4B but doesn't "need a big acquisition in the short term." Novartis is looking to buy assets to offset patent expirations, with Jimenez saying the firm wants to expand its generics business with respiratory and dermatology treatments, and injectable cancer therapies. The company won't sell its loss-making vaccines ops or other smaller units.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs